SYNGAP1 — Synaptic Ras GTPase Activating Protein 1

SYNGAP1 — Synaptic Ras GTPase Activating Protein 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptic Ras GTPase Activating Protein 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SYNGAP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Synaptic Ras GTPase Activating Protein 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>6p21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6840](https://www.ncbi.nlm.nih.gov/gene/6840)</td></tr>
<tr><td><strong>OMIM</strong></td><td>603384</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000197283</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9ULB0](https://www.uniprot.org/uniprot/Q9ULB0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Intellectual Disability, Autism, Epilepsy, Alzheimer's Disease, Schizophrenia</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus)), postsynaptic densities</td></tr>
</table>
</div>

Overview

SYNGAP1 — Synaptic Ras GTPase Activating Protein 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Synaptic Ras GTPase Activating Protein 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SYNGAP1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Synaptic Ras GTPase Activating Protein 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>6p21.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6840](https://www.ncbi.nlm.nih.gov/gene/6840)</td></tr>
<tr><td><strong>OMIM</strong></td><td>603384</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000197283</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9ULB0](https://www.uniprot.org/uniprot/Q9ULB0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Intellectual Disability, Autism, Epilepsy, Alzheimer's Disease, Schizophrenia</td></tr>
<tr><td><strong>Expression</strong></td><td>Brain ([cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus)), postsynaptic densities</td></tr>
</table>
</div>

Overview

SYNGAP1 (Synaptic Ras GTPase Activating Protein 1) encodes SynGAP, a critical synaptic Ras GTPase-activating protein that is highly enriched in excitatory synapses. SynGAP is a major postsynaptic density (PSD) protein that regulates Ras signaling and controls AMPA receptor trafficking, making it essential for synaptic plasticity, learning, and memory. [@kim2001]

SYNGAP1 is one of the most abundant proteins in the postsynaptic density, comprising approximately 1-2% of total synaptic protein. It acts as a key regulator of synaptic signaling by controlling the activity of Ras GTPases at the postsynaptic membrane. [@chen1998]

Gene and Protein Structure

Gene Organization

The SYNGAP1 gene is located on chromosome 6p21.3 and encodes a protein of 1343 amino acids with a molecular weight of ~150 kDa. The gene contains multiple functional domains:

• N-terminal domain: Contains a C2 domain (Ca²⁺/lipid-binding)
• PDZ-binding motif: Mediates interaction with PSD-95 and other scaffolding proteins
• SH3 domain: Protein-protein interactions
• GAP domain: Catalytic Ras GTPase-activating function
• C-terminal region: Regulatory sequences

Protein Isoforms

Multiple isoforms of SynGAP exist due to alternative splicing:

• SynGAP-α1: Full-length isoform with complete GAP domain
• SynGAP-α2: Alternative C-terminus, different regulatory properties
• SynGAP-β: Truncated isoform lacking parts of the GAP domain

Function

Normal Physiological Function

Ras GTPase Regulation

SynGAP is a potent Ras GTPase-activating protein that accelerates the hydrolysis of Ras-GTP to Ras-GDP, thereby inactivating Ras signaling. In thePostsynaptic density, SynGAP is positioned to regulate:

• Ras-ERK signaling: Controls activity-dependent gene expression
• Rap signaling: Modulates AMPA receptor trafficking
• mTOR pathway: Regulates protein synthesis at synapses

NMDA Receptor Signaling

SynGAP interacts closely with NMDA receptor signaling:

• Phosphorylation by CaMKII: Activity-dependent phosphorylation enhances SynGAP function
• Interaction with PSD-95: Forms a complex with NMDA receptors
• Regulation of downstream effectors: Controls Ras-ERK and other pathways

AMPA Receptor Trafficking

SynGAP plays a critical role in AMPA receptor trafficking:

• Controls membrane insertion: Ras signaling regulates AMPA receptor delivery
• Synaptic plasticity: Required for long-term potentiation (LTP) and long-term depression (LTD)
• Synaptic strength: Modifies synaptic responses

Dendritic Spine Morphology

SynGAP influences dendritic spine structure:

• Spine size: Controls spine head volume
• Spine density: Regulates number of spines
• Spine stability: Affects spine turnover

Expression Pattern

SYNGAP1 shows high expression in brain:

• Hippocampus: Highest expression in CA1 region
• Cortex: Layer-specific expression in pyramidal neurons
• Striatum: Medium spiny neuron expression
• Cerebellum: Purkinje cell expression

Disease Associations

Intellectual Disability

SYNGAP1 is one of the most common genetic causes of intellectual disability:

• Prevalence: ~1% of all intellectual disability cases
• Inheritance: De novo dominant mutations
• Mechanism: Haploinsufficiency due to loss-of-function mutations
• Phenotype: Moderate to severe intellectual disability, speech delay

Clinical features:

• Global developmental delay
• Absent or severely delayed speech
• Moderate to severe intellectual disability
• Hypotonia in infancy
• Behavioral problems (autism, ADHD)
• Facial dysmorphism in some cases

Autism Spectrum Disorder

SYNGAP1 mutations are strongly associated with [autism spectrum disorder](/diseases/autism):

• Comorbidity: ~60% of individuals with SYNGAP1 mutations meet autism criteria
• Shared mechanisms: Synaptic dysfunction and altered plasticity
• Therapeutic targets: mTOR inhibitors, AMPA modulators under investigation

Epilepsy

Epilepsy is a common manifestation of SYNGAP1 mutations:

• Prevalence: ~80% of individuals with SYNGAP1 mutations have epilepsy
• Seizure types: Generalized tonic-clonic, absence, myoclonic
• Onset: Typically in early childhood
• Treatment: Antiepileptic drugs, ketogenic diet in some cases

Alzheimer's Disease

SynGAP alterations are found in [Alzheimer's disease](/diseases/alzheimers-disease):

• Expression changes: Altered SynGAP levels in AD brain
• AMPA receptor dysfunction: Contributes to synaptic failure
• Ras-ERK dysregulation: Affects synaptic plasticity
• Interaction with amyloid-beta: Amyloid-beta affects SynGAP function

Schizophrenia

SynGAP is implicated in [schizophrenia](/diseases/schizophrenia):

• Genetic association: Rare variants in schizophrenia cohorts
• Expression changes: Altered SynGAP in prefrontal cortex
• Dysbindin interaction: SynGAP interacts with schizophrenia risk gene

Other Disorders

• Attention deficit hyperactivity disorder (ADHD): Common comorbidity
• Bipolar disorder: Rare associations reported
• Rett syndrome: Overlapping phenotypes in females

Therapeutic Implications

Therapeutic Strategies

Current Research Directions

• ASO therapy: Antisense oligonucleotides to increase expression
• Protein replacement: Delivery of functional SynGAP protein
• Cell-type specific approaches: Targeted delivery to excitatory neurons

Biomarker Potential

• CSF markers: SynGAP levels as synaptic health indicator
• iPSC models: Patient-derived neurons for drug screening
• Electrophysiology: EEG biomarkers for treatment response

Research Highlights

Key Findings

Mouse Models

• Syngap1⁺/⁻ mice: Recapitulate key features of human phenotype
• Conditional knockouts: Reveal cell-type specific functions
• Rescue studies: Demonstrate reversibility of phenotypes

Background

The study of Syngap1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Synaptic Proteins](/mechanisms/synaptic-proteins)
• [Intellectual Disability](/diseases/intellectual-disability)
• [Autism Spectrum Disorder](/diseases/autism)
• [Epilepsy](/diseases/epilepsy)
• [SynGAP Protein](/proteins/syngap1-protein)
• [AMPA Receptor Signaling](/mechanisms/ampa-receptor-signaling)
• [Ras-ERK Signaling](/mechanisms/ras-erk-signaling)

External Links

• [NCBI Gene Database](https://www.ncbi.nlm.nih.gov/gene/6840)
• [UniProt Protein Database](https://www.uniprot.org/uniprot/Q9ULB0)
• [OMIM](https://omim.org/entry/603384)
• [Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000197283)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving SYNGAP1 — Synaptic Ras GTPase Activating Protein 1 discovered through SciDEX knowledge graph analysis: